Browse studies, page 1195
Page 1195 of 1,197, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Comparison of Pathogen Eradication Rate and Safety of Anti-Bacterial Agents for Bronchitis: A Network Meta-Analysis Journal of cellular biochemistry, 2017
- Efficacy and safety of drug therapies for treating tuberculous meningitis: a network meta-analysis Journal of infection in developing countries, 2026
- An Updated Systematic Review and Meta-Analysis on the Helicobacter pylori Antibiotic Resistance in Iran (2010-2020) Microbial drug resistance (Larchmont, N.Y.), 2020
- Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis BMJ open gastroenterology, 2020
- Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta-Analysis Helicobacter, 2025
- Trends of fluoroquinolones resistance in Mycoplasma and Ureaplasma urogenital isolates: Systematic review and meta-analysis Journal of global antimicrobial resistance, 2024
- Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis The Journal of infectious diseases, 2024
- Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis. Multicenter study: Argentina 2011-2012 Revista Argentina de microbiologia, 2016
- Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis Hematology (Amsterdam, Netherlands), 2019
- Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis Helicobacter, 2018
- The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta-analysis Helicobacter, 2020
- Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024
- A systematic review and meta-analysis of comparative clinical studies on antibiotic treatment of brucellosis Scientific reports, 2024
- Antibiotic Resistance of Helicobacter pylori in Turkey: A Systematic Review and Meta-Analysis Microbial drug resistance (Larchmont, N.Y.), 2023
- Antibiotics for community-acquired pneumonia in children The Cochrane database of systematic reviews, 2010
- Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis Microbial pathogenesis, 2022
- Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection Antimicrobial agents and chemotherapy, 2013
- The effects of adding quinolones to beta-lactam antibiotics for sepsis Acta anaesthesiologica Scandinavica, 2021
- Drug treatment of scrub typhus: a systematic review and meta-analysis of controlled clinical trials Transactions of the Royal Society of Tropical Medicine and Hygiene, 2017
- The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis Helicobacter, 2020
- Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis European journal of clinical pharmacology, 2019
- A meta-analytic perspective on Arcobacter spp. antibiotic resistance Journal of global antimicrobial resistance, 2019
- Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis Medicine, 2017
- Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysis International journal of antimicrobial agents, 2024
- Fluoroquinolones for treating tuberculosis The Cochrane database of systematic reviews, 2005
- Fluoroquinolones for treating tuberculosis The Cochrane database of systematic reviews, 2008
- The prevalence of antibiotic-resistant Clostridium species in Iran: a meta-analysis Pathogens and global health, 2019
- Meta-analysis of fluoroquinolones versus macrolides for treatment of legionella pneumonia Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021
- Safety of Quinolones in Children: A Systematic Review and Meta-Analysis Paediatric drugs, 2022
- Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis The Journal of infection, 2018
- A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis NEJM evidence, 2025
- Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults Medicine, 2020
- A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection Annals of palliative medicine, 2021
- Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis Journal of Korean medical science, 2015
- Respiratory fluoroquinolone monotherapy versus β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomised controlled trials International journal of antimicrobial agents, 2023
- Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023
- Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis The lancet. Gastroenterology & hepatology, 2024
- Identifying the Best Initial Oral Antibiotics for Adults with Community-Acquired Pneumonia: A Network Meta-Analysis Journal of general internal medicine, 2024
- Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis BMC medicine, 2024
- Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta-Analysis Helicobacter, 2024
- Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis Journal of comparative effectiveness research, 2025
- Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis The Lancet. Respiratory medicine, 2020
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions Gastroenterology, 2018
- Mesoporous Silica Nanoparticles Decorated with Polycationic Dendrimers for Infection Treatment Acta Biomaterialia. 68, 261-271 (2018), 2021
- Molecular gates in mesoporous bioactive glasses for the treatment of bone tumors and infection Acta Biomaterialia 50, 114-126 (2017), 2021
- Impact of the antibiotic-cargo from MSNs on Gram-positive and Gram-negative bacterial biofilms Microporous and Mesoporous Materials 311 (2021), 110681, 2021
- Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection Acta Biomaterialia 114, 395-406 (2020), 2021
- A Novel Semi-Supervised Algorithm for Rare Prescription Side Effect Discovery IEEE Journal of Biomedical and Health Informatics, 18 (2), pp. 537-547, 2014, 2014
- Concanavalin A-targeted mesoporous silica nanoparticles for infection treatment Acta Biomaterialia. 96, 547-556 (2019), 2021
- A versatile multicomponent mesoporous silica nanosystem with dual antimicrobial and osteogenic effects Acta Biomaterialia 136 (2021) 570 to 581, 2021
- Effective reduction of biofilm through photothermal therapy by gold core@shell based mesoporous silica nanoparticles Microporous and Mesoporous Materials 328 (2021) 111489, 2021
- 3D scaffold with effective multidrug sequential release against bacteria biofilm Acta Biomaterialia. 49, 113-126 (2017), 2021
- Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection Acta Biomaterialia. 65, 450-461 (2018), 2021
- In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy, 1998
- Inhibitors of Efflux Pumps in Pseudomonas a eruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin Journal of Medicinal Chemistry, 1999
- Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy The Journal of Infectious Diseases, 2001
- Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death The Annals of Family Medicine, 2014
- Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens CHEST Journal, 2000
- Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial JAMA, 2018
- Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection Antimicrobial Agents and Chemotherapy, 1999
- Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides Clinical Infectious Diseases, 2005
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI) The Lancet, 2015
- Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis. CME The American Journal of Gastroenterology, 2006
- Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis PubMed, 2006
- Bacteremia Due to Viridans Group Streptococci with Diminished Susceptibility to Levofloxacin among Neutropenic Patients Receiving Levofloxacin Prophylaxis Clinical Infectious Diseases, 2002
- Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses Antimicrobial Agents and Chemotherapy, 1997
- Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis Antimicrobial Agents and Chemotherapy, 2007
- Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study Clinical Infectious Diseases, 2001
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy, 1999
- A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia Antimicrobial Agents and Chemotherapy, 1997
- Levofloxacin, a second-generation fluoroquinolone Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 1998
- In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin Antimicrobial Agents and Chemotherapy, 1992
- Levofloxacin: a therapeutic review Clinical Therapeutics, 1998
- Adsorption behavior of the antibiotic levofloxacin on microplastics in the presence of different heavy metals in an aqueous solution Chemosphere, 2020
- Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure Alimentary Pharmacology & Therapeutics, 2005
- Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract Drugs, 1998
- High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Clinical Infectious Diseases, 2003
- Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection Drugs, 2008
- Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway Journal of Neuroinflammation, 2019
- Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia New England Journal of Medicine, 2002
- Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia New England Journal of Medicine, 2005
- Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials JAMA, 1998
- Randomized Controled Multicentric Trial, of Non Inferiority, Comparing Two Durations of Antibiotherapy (5 Days Versus 10 Days) in COMMUNAUTARY Acute Uncomplicated Pyelonephritis ClinicalTrials.gov · COMPLETED, 2011
- A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery ClinicalTrials.gov · TERMINATED
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared With Ertapenem in Complicated Urinary Tract Infections ClinicalTrials.gov · COMPLETED, 2018
- Assessment of the Effects and Tolerability of RD03/2016 (Levofloxacin; Ketorolac Trometamol 0.5+0.5% w/v Eye Drops Solution) for the Treatment of Bacterial Conjunctivitis in Adults: a Multicentre, Randomized, Blinded-assessor, Phase II Non Inferiority Study - MIRAKLE ClinicalTrials.gov · COMPLETED, 2023
- Comparing the Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinidazole on Rate of Eradication of Helicobacter Pylori Infected Patients on Syrian Population ClinicalTrials.gov · COMPLETED, 2020
- A Single- Centre, Randomised Study Of The Clinical And Microbiological Efficacy Of Decreasing The Dosage Of Levofloxacin 0,5% Eye Drops As Compared To Standard Eye Drop Dosage In Patients With Bacterial Conjunctivitis ClinicalTrials.gov · COMPLETED, 2006
- Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection - a Multi-center Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2020
- Phase I Clinical Trial, to Evaluate the Safety and Tolerability of the Ophthalmic Solution PRO-174 Versus Sophixín Ofteno®, Elaborated by Laboratorios Sophia on the Ocular Surface of Ophthalmological and Clinically Healthy Subjects ClinicalTrials.gov · COMPLETED, 2018
- Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics ClinicalTrials.gov · TERMINATED, 2018
- Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection-A Randomized Clinical Trial ClinicalTrials.gov · COMPLETED, 2019
- Aqueous Humour Concentrations After Topical apPlication of combinEd Levofloxacin-dexamethasone Eye dRops and of Its Single Components: a randoMized, assEssor-blinded, Parallel-group Study in Patients Undergoing Cataract Surgery - iPERME ClinicalTrials.gov · COMPLETED, 2018
- A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis ClinicalTrials.gov · COMPLETED, 2024
- An Open-label, Randomized, 3-way Crossover Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2002
- A Multicenter, Active-Controlled, Randomized Study to Evaluate the Safety and Efficacy of Oral Levofloxacin Versus Cefaclor in the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis in Adults ClinicalTrials.gov · COMPLETED, 1994
- Phase 4 Study of Azitromicin in the Treatment of PID ClinicalTrials.gov · COMPLETED, 2010
- Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment ClinicalTrials.gov · COMPLETED, 2009
- Evaluation of Two Strategies of Antibiotic Treatment With Levofloxacin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Short Treatment-versus Treatment Guided by Markers of Inflammation ClinicalTrials.gov · COMPLETED, 2019
- Assessment of Hematological Effect of H.Pylori and H.Pylori Eradication Therapy Among a Sample of Iraqi ITP Patients ClinicalTrials.gov · COMPLETED, 2025
